Search

Po-chih Chen

Examiner (ID: 4660, Phone: (571)270-7243 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1621, 1626
Total Applications
924
Issued Applications
609
Pending Applications
121
Abandoned Applications
231

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13551727 [patent_doc_number] => 20180327411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => INDOLE AHR INHIBITORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/958586 [patent_app_country] => US [patent_app_date] => 2018-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 108676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 437 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15958586 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/958586
Indole AHR inhibitors and uses thereof Apr 19, 2018 Issued
Array ( [id] => 16297648 [patent_doc_number] => 20200283371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-10 [patent_title] => PHARMACEUTICALLY ACCEPTABLE SALT OF ALKYLCARBAMOYL NAPHTHALENYLOXY OCTENOYLHYDROXYAMIDE OR OF DERIVATIVE THEREOF AND METHOD FOR PREPARING SAME [patent_app_type] => utility [patent_app_number] => 16/616547 [patent_app_country] => US [patent_app_date] => 2018-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616547 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/616547
Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of derivative thereof and method for preparing same Apr 17, 2018 Issued
Array ( [id] => 16786037 [patent_doc_number] => 10988449 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-27 [patent_title] => Isoxazole derivatives as nuclear receptor agonists and uses thereof [patent_app_type] => utility [patent_app_number] => 16/604180 [patent_app_country] => US [patent_app_date] => 2018-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36629 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604180 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604180
Isoxazole derivatives as nuclear receptor agonists and uses thereof Apr 11, 2018 Issued
Array ( [id] => 16012573 [patent_doc_number] => 20200181129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => CARBAZOLE COMPOUNDS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/604532 [patent_app_country] => US [patent_app_date] => 2018-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604532 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604532
Carbazole compounds and methods of use thereof Apr 10, 2018 Issued
Array ( [id] => 17905468 [patent_doc_number] => 11459311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-04 [patent_title] => Pharmaceutical composition containing indirubin derivative as active ingredient [patent_app_type] => utility [patent_app_number] => 16/606089 [patent_app_country] => US [patent_app_date] => 2018-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5760 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606089 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/606089
Pharmaceutical composition containing indirubin derivative as active ingredient Apr 9, 2018 Issued
Array ( [id] => 17228562 [patent_doc_number] => 20210355118 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => COMPOUNDS AND THEIR METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/500795 [patent_app_country] => US [patent_app_date] => 2018-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -74 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500795 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/500795
Compounds and their methods of use Apr 3, 2018 Issued
Array ( [id] => 18186358 [patent_doc_number] => 11576916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Methods of preventing or treating ophthalmic diseases [patent_app_type] => utility [patent_app_number] => 16/500504 [patent_app_country] => US [patent_app_date] => 2018-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17965 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500504 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/500504
Methods of preventing or treating ophthalmic diseases Apr 2, 2018 Issued
Array ( [id] => 16525131 [patent_doc_number] => 20200399211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => ALKYL SULFATE ESTER OR SALT OF SAME [patent_app_type] => utility [patent_app_number] => 16/498576 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498576 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/498576
Alkyl sulfate ester or salt of same Mar 29, 2018 Issued
Array ( [id] => 13300159 [patent_doc_number] => 20180201616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-19 [patent_title] => 3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives [patent_app_type] => utility [patent_app_number] => 15/923948 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46683 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 1063 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15923948 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/923948
3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives Mar 15, 2018 Abandoned
Array ( [id] => 13357081 [patent_doc_number] => 20180230080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => ADENYLYL CYCLASE INHIBITORS FOR NEUROPATHIC AND INFLAMMATORY PAIN [patent_app_type] => utility [patent_app_number] => 15/920654 [patent_app_country] => US [patent_app_date] => 2018-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14274 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15920654 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/920654
Adenylyl cyclase inhibitors for neuropathic and inflammatory pain Mar 13, 2018 Issued
Array ( [id] => 17297765 [patent_doc_number] => 20210393604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => NOVEL BENZIMIDAZOLONE COMPOUND AND PHARMACEUTICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/494168 [patent_app_country] => US [patent_app_date] => 2018-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15692 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 1067 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494168 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494168
NOVEL BENZIMIDAZOLONE COMPOUND AND PHARMACEUTICAL USE THEREOF Mar 13, 2018 Abandoned
15/915958 Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof Mar 7, 2018 Abandoned
Array ( [id] => 15407935 [patent_doc_number] => 20200024289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => NOVEL OXABOROLE ANALOGS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/489824 [patent_app_country] => US [patent_app_date] => 2018-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28367 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489824 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489824
Oxaborole analogs and uses thereof Feb 28, 2018 Issued
Array ( [id] => 18964089 [patent_doc_number] => 11897838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-13 [patent_title] => High-purity isothiocyanate compound preparation method for industrial production [patent_app_type] => utility [patent_app_number] => 16/489226 [patent_app_country] => US [patent_app_date] => 2018-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4494 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 307 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489226 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489226
High-purity isothiocyanate compound preparation method for industrial production Feb 26, 2018 Issued
Array ( [id] => 15360797 [patent_doc_number] => 20200016163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => TREATMENT OF DEMENTIA WITH CANNABINOID AGONISTS [patent_app_type] => utility [patent_app_number] => 16/489110 [patent_app_country] => US [patent_app_date] => 2018-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6068 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 238 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489110 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/489110
TREATMENT OF DEMENTIA WITH CANNABINOID AGONISTS Feb 22, 2018 Abandoned
Array ( [id] => 18716461 [patent_doc_number] => 11793782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-24 [patent_title] => Therapeutic agents for neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 16/756948 [patent_app_country] => US [patent_app_date] => 2018-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 53 [patent_no_of_words] => 28369 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756948 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/756948
Therapeutic agents for neurodegenerative diseases Feb 14, 2018 Issued
Array ( [id] => 18187498 [patent_doc_number] => 11578067 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Compound, and method for producing regulatory T cells [patent_app_type] => utility [patent_app_number] => 16/479229 [patent_app_country] => US [patent_app_date] => 2018-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 18 [patent_no_of_words] => 13008 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479229 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/479229
Compound, and method for producing regulatory T cells Jan 29, 2018 Issued
Array ( [id] => 13342625 [patent_doc_number] => 20180222852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => Synthesis of Methyl Carbamate and Dimethyl Carbonate (DMC) in Presence of Stripping with Inert Gas or Superheated Vapours and a Reactor for the Same [patent_app_type] => utility [patent_app_number] => 15/883912 [patent_app_country] => US [patent_app_date] => 2018-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7906 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15883912 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/883912
Synthesis of methyl carbamate and dimethyl carbonate (DMC) in presence of stripping with inert gas or superheated vapours and a reactor for the same Jan 29, 2018 Issued
Array ( [id] => 15054699 [patent_doc_number] => 10457638 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B [patent_app_type] => utility [patent_app_number] => 15/875929 [patent_app_country] => US [patent_app_date] => 2018-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65924 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875929 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/875929
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B Jan 18, 2018 Issued
Array ( [id] => 13051381 [patent_doc_number] => 10047071 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2018-08-14 [patent_title] => Dihydropyrimidinone derivatives [patent_app_type] => utility [patent_app_number] => 15/871927 [patent_app_country] => US [patent_app_date] => 2018-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3003 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15871927 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/871927
Dihydropyrimidinone derivatives Jan 14, 2018 Issued
Menu